MDT241101P120000
- 0.00
- 0.000.00%
Medtronic Newsroom
Shares Of Boston Scientific See Volume; Company To Provide Cardiology Business Update At 4:00 PM EDT
Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock
MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System
Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note
Medtronic Announces Long-Term Data From Its SPYRAL HTN-ON MED Clinical Trial That Showed Subjects Who Underwent Radiofrequency Renal Denervation With The Symplicity Spyral Renal Denervation System Had Greater Reductions In 24-Hr ABPM, And OSBP...
Express News | Spyral Htn-on Med Study Shows Significant, Consistent, Long-Term Blood Pressure Lowering Effect at Two Years
SPYRAL HTN-ON MED Study Shows Significant, Consistent, Long-term Blood Pressure Lowering Effect at Two Years
Internet of Medical Things (IoMT) Market Report 2024-2034, Featuring Profiles of Baxter, Bio Techne, Biotronik, Boston Scientific, Cisco Systems, GE Healthcare, IBM, Medtronic, Siemens and More
Medtronic's (NYSE:MDT) Returns Have Hit A Wall
Medtronic Analyst Ratings
Apple Reportedly Tests a Blood Sugar App
Medtronic' Affera, Sphere-9 Offering Is Threat to Boston Scientific -- Market Talk
Needham Maintains Medtronic(MDT.US) With Hold Rating
Medtronic's Sphere-9: Promising FDA Approval Amidst Production Uncertainties
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
Medtronic (MDT) Gets a Hold From Stifel Nicolaus
Express News | A New Paradigm in Electrophysiology: Medtronic Receives FDA Approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
A New Paradigm in Electrophysiology: Medtronic Receives FDA Approval of Affera Mapping and Ablation System and Sphere-9 Catheter
Medtronic Wins CE Mark for Evolut FX+
Philips Teams Up With Medtronic For Stroke Diagnosis